Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Participants With Moderate Hepatic Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04573582
What this trial is testing

Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment

Who this might be right for
Hepatic Impairment
Celgene 40
Early research (Phase 1)Looking for participantsNCT07694843
What this trial is testing

A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function

Who this might be right for
Healthy ParticipantsParticipants With Mild Hepatic ImpairmentParticipants With Moderate Hepatic Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 24
Early research (Phase 1)Study completedNCT00819468
What this trial is testing

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Who this might be right for
Hepatic Impairment
Shire 24
Early research (Phase 1)Looking for participantsNCT04271488
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants

Who this might be right for
Hepatic Impairment
Eisai Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06962332
What this trial is testing

Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)

Who this might be right for
Hepatic ImpairmentModerate Hepatic Impairment
Exelixis 20
Early research (Phase 1)Study completedNCT06425198
What this trial is testing

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Participants
Bristol-Myers Squibb 37
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Early research (Phase 1)Study completedNCT06352528
What this trial is testing

Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Bristol-Myers Squibb 18
Early research (Phase 1)Looking for participantsNCT07809802
What this trial is testing

Pharmacokinetic Study of Vorolanib Tablets in Trial Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment (HI)
Betta Pharmaceuticals Co., Ltd. 36
Early research (Phase 1)Study completedNCT05607173
What this trial is testing

A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Function Abnormal
Sanofi 21
Early research (Phase 1)Study completedNCT02001571
What this trial is testing

Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function

Who this might be right for
Prostate Cancer
Cougar Biotechnology, Inc. 24
Early research (Phase 1)Study completedNCT05599932
What this trial is testing

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT06340347
What this trial is testing

Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function

Who this might be right for
Liver Diseases
Pfizer 8
Early research (Phase 1)Looking for participantsNCT07480824
What this trial is testing

To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

Who this might be right for
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT07751250
What this trial is testing

Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function

Who this might be right for
Healthy ParticipantsHepatic Impairment
Arcus Biosciences, Inc. 16
Early research (Phase 1)Study completedNCT05404529
What this trial is testing

To Evaluate the Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Mild and Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Cerevel Therapeutics, LLC 32
Early research (Phase 1)Ended earlyNCT04332523
What this trial is testing

JNJ-53718678 in Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Janssen Research & Development, LLC 25
Early research (Phase 1)Study completedNCT04942964
What this trial is testing

Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 25
Post-approval studies (Phase 4)Ended earlyNCT03633227
What this trial is testing

Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

Who this might be right for
Liver Cirrhosis, Biliary
Intercept Pharmaceuticals 22
Early research (Phase 1)Study completedNCT02524717
What this trial is testing

Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Aragon Pharmaceuticals, Inc. 24
Next Page